Search

Objectives The present study aimed to document the use of the wound infusion catheter (WIC) following a variety of surgical procedures in cats, investigating complications and risk factors associated with catheter placement or local anaesthetic (LA) administration. Methods A retrospective, multicentric study was performed. Medical databases of eight veterinary referral hospitals from 2010 to 2021 were searched to identify records of cats where WICs were used. Information regarding signalment, type of surgery, size and type of WIC placed, and LA protocol used, as well as postoperative complications, were retrieved. Results One hundred and sixty-six cases fulfilled the inclusion criteria. Feline injection site sarcoma resection was the most common surgery. Overall complications were identified in 22/166 cats (13.2%). Thirteen cats (7.8%) experienced wound-related complications, whereas nine cats (5.4%) experienced drug-delivery complications. The only factor associated with an increased risk of complications was the amount of a single dose of LA delivered through the catheter ( P <0.001). An amount higher than 2.5 ml of LA delivered at each administration was associated with an increased risk of complications. All complications were minor and self-limiting. Conclusions and relevance WICs were used for a large variety of surgical procedures with different protocols of LA administration as part of a multimodal analgesic plan in cats. The risk of complications was relatively low and self-limiting, suggesting its safe use in cats. Further prospective studies are required to evaluate efficacy of postoperative analgesia and to determine the suitable protocol for WIC handling and maintenance.

Local recurrence after surgical excision of canine massive hepatocellular carcinoma (HCC) has been poorly studied in veterinary medicine with scant information published regarding risk factors for and outcome following recurrence. The aim of this case-control study was to describe the time to recurrence, evaluate potential risk factors for recurrence, and report the outcome in dogs with massive HCC. Medical records for 75 dogs who developed recurrence and 113 dogs who did not develop recurrence were reviewed. Statistical analyses were performed to determine risk factors for recurrence as well as the median time to develop recurrence and overall survival time (OS). None of the risk factors evaluated were significant for the development of recurrence. The median time to develop recurrence was 367 days (range 32-2096 days). There was no significant difference in median OS for dogs who developed recurrence vs. those who did not (851 vs. 970 days). For dogs with recurrent HCC, treatment at recurrence trended toward prolonged OS but was not significantly different from dogs not undergoing treatment at recurrence. There was no significant difference in median OS for dogs with histologically complete vs. incomplete tumour excision (990 vs. 903 days). Although specific risk factors for recurrence were not identified, elevations in liver values were noted in patients with recurrent disease and could act as a noninvasive surveillance tool. Recurrence was noted earlier in dogs who had routine post-operative surveillance (228 vs. 367 days). Routine surveillance for recurrence is recommended especially in dogs where further intervention is possible and should extend beyond 1 year. Patients with massive HCC have a good long-term prognosis regardless of incomplete excision, pulmonary metastasis, or recurrent local disease.

When a patient with chronic renal failure is told he must undergo hemodialysis, he/she lives an emotional shock, followed by a phase of anxiety. If this shock can’t be overcome, the patient can face some anxious-depressive pathologies that will complicate the already complex clinical picture. The aim of this work is to demonstrate how the communicative/educational measures are the clinical instruments, applied especially by nurses, that lead the patient to the acquisition of different skills (such as self-reliance and psycho-social abilities). In conclusion, an efficient communication, mainly based on active and participative listening, represents the most effective instrument for the patient with chronic-degenerative pathologies to promote the awareness of his own capacities of self-management, and to make him play a leading role in his own health.

When a patient with chronic renal failure is told he must undergo hemodialysis, he/she lives an emotional shock, followed by a phase of anxiety. If this shock can’t be overcome, the patient can face some anxious-depressive pathologies that will complicate the already complex clinical picture. The aim of this work is to demonstrate how the communicative/educational measures are the clinical instruments, applied especially by nurses, that lead the patient to the acquisition of different skills (such as self-reliance and psycho-social abilities). In conclusion, an efficient communication, mainly based on active and participative listening, represents the most effective instrument for the patient with chronic-degenerative pathologies to promote the awareness of his own capacities of self-management, and to make him play a leading role in his own health. (narrative nephrology), When a patient with chronic renal failure is told he must undergo hemodialysis, he/she lives an emotional shock, followed by a phase of anxiety. If this shock can’t be overcome, the patient can face some anxious-depressive pathologies that will complicate the already complex clinical picture. The aim of this work is to demonstrate how the communicative/educational measures are the clinical instruments, applied especially by nurses, that lead the patient to the acquisition of different skills (such as self-reliance and psycho-social abilities). In conclusion, an efficient communication, mainly based on active and participative listening, represents the most effective instrument for the patient with chronic-degenerative pathologies to promote the awareness of his own capacities of self-management, and to make him play a leading role in his own health. (narrative nephrology)

Pheochromocytoma is frequent in dogs and carries a guarded prognosis. Current histological criteria may not predict malignant behavior in dogs, similar to humans. In humans, characterization of tumors has been refined using the pheochromocytoma of the adrenal gland scaled score (PASS) and by immunohistochemistry. The study aim was to investigate PASS and immunohistochemical markers used in humans in 24 dogs with pheochromocytoma that underwent adrenalectomy. Dogs with pheochromocytomas were reviewed and tumors collected. Histological sections were evaluated to apply the PASS and were single-labeled for chromogranin A, Ki-67, COX-2, p53, BCL-2, c-erbB-2, vascular endothelial growth factor, and S100. Survival, age, and vascular and capsular invasion were compared for PASS and immunohistochemical markers; results of PASS were also compared for each marker. Associations between markers were tested. PASS and immunohistochemical markers did not differ for survival, age, and vascular and capsular invasion. Tumors showing BCL-2 expression in >50% cells had lower PASS than those with lower expression (PASS: 7 ± 2 vs 9 ± 2; P = .011). Tumors positive for S100 had higher PASS than those that were negative (PASS: 10 ± 2 vs 7 ± 2; P = .001). Results of the different markers were not associated. In conclusion, in the context of canine pheochromocytoma, PASS and the selected immunohistochemical markers are not associated with survival, age, or vascular or capsular invasion. The higher PASS in S100-positive tumors may indicate that pheochromocytomas developing morphologic changes acquire S100 expression. The significance of lower PASS in tumors with elevated BCL-2 expression is uncertain. Overall, the use of PASS and the present immunohistochemical markers may not be useful in dogs with pheochromocytoma.